PODLOGAR SUSAN M
SEC CIK 1709959 · EDGAR
BoughtSold
Most active insiders at TVGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Flomenberg Neal | See Remarks | — | $6,635 |
| 2 | Feike Jeffrey L. | Dir | — | — |
| 3 | Desai Kirti | CFO | — | — |
| 4 | Goh Keow Lin | Dir | — | — |
| 5 | Patton Curtis L. | Dir | — | — |
| 6 | Sordillo Victor J. | Dir | — | — |
| 7 | Saadi Ryan H. | CEO, Dir, 10% | — | — |
| 8 | PODLOGAR SUSAN M | Dir | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 20:05 | 2026-09-11 | TVGN | Tevogen Inc. | PODLOGAR SUSAN M | Dir | A - Grant | $0.00 | +75.0K | 123.7K | +154% | $0 | |
| 2026-07-10 17:31 | 2026-07-10 | TVGN | Tevogen Inc. | PODLOGAR SUSAN M | Dir | A - Grant | $0.00 | +40.0K | 48.7K | +461% | $0 | |
| D | 2026-06-17 16:09 | 2026-06-15 | LIVN | LivaNova PLC | PODLOGAR SUSAN M | Dir | M - OptEx | $0.00 | +4,042 | 6,128 | +194% | $0 |
| D | 2026-06-17 16:09 | 2026-06-15 | LIVN | LivaNova PLC | PODLOGAR SUSAN M | Dir | F - Tax | $79.70 | -486 | 5,642 | -8% | -$38.7K |
| D | 2025-12-17 | 2025-12-15 | LIVN | LivaNova PLC | PODLOGAR SUSAN M | Dir | M - OptEx | $0.00 | +2,355 | 2,355 | New | $0 |
| D | 2025-12-17 | 2025-12-15 | LIVN | LivaNova PLC | PODLOGAR SUSAN M | Dir | F - Tax | $63.06 | -269 | 2,086 | -11% | -$17.0K |
| 2024-12-26 | 2024-12-23 | TVGN | Tevogen Inc. | PODLOGAR SUSAN M | Dir | A - Grant | $0.00 | +240.0K | 433.9K | +124% | $0 | |
| 2024-03-05 | 2024-03-01 | MET | MetLife | PODLOGAR SUSAN M | EVP, Chief HR Off | F - Tax | $69.73 | -1,907 | 79.8K | -2% | -$133.0K | |
| D | 2024-02-29 | 2024-02-27 | MET | MetLife | PODLOGAR SUSAN M | EVP, Chief HR Off | F - Tax | $69.16 | -13.8K | 81.7K | -14% | -$955.9K |
| DM | 2024-02-29 | 2024-02-27 | MET | MetLife | PODLOGAR SUSAN M | EVP, Chief HR Off | A - Grant | — | +31.0K | 68.6K | +82% | — |
| 2024-02-16 | 2024-02-14 | TVGN | Tevogen Inc. | PODLOGAR SUSAN M | Dir | A - Grant | — | +193.9K | 193.9K | New | — | |
| DM | 2023-03-02 | 2023-02-28+ | MET | MetLife | PODLOGAR SUSAN M | EVP, Chief HR Off | F - Tax | $71.67 | -15.2K | 66.5K | -19% | -$1.09M |
| DM | 2023-03-02 | 2023-02-28 | MET | MetLife | PODLOGAR SUSAN M | EVP, Chief HR Off | A - Grant | — | +33.6K | 79.7K | +73% | — |
| 2022-12-22 | 2022-12-20 | MET | MetLife | PODLOGAR SUSAN M | EVP, Chief HR Off | S - Sale | $71.91 | -3,000 | 46.2K | -6% | -$215.7K | |
| 2022-03-03 | 2022-03-01 | MET | MetLife | PODLOGAR SUSAN M | EVP, Chief HR Off | F - Tax | $64.44 | -2,056 | 49.2K | -4% | -$132.5K | |
| DM | 2022-02-24 | 2022-02-22 | MET | MetLife | PODLOGAR SUSAN M | EVP, Chief HR Off | A - Grant | — | +30.2K | 62.7K | +93% | — |
| D | 2022-02-24 | 2022-02-22 | MET | MetLife | PODLOGAR SUSAN M | EVP, Chief HR Off | F - Tax | $68.96 | -11.4K | 51.2K | -18% | -$788.8K |
Purchase Sale Sale after option exercise All abbreviations